American Board of Artificial Intelligence in Medicine (ABAIM) Aims toEducate and Certify Healthcare Professionals in AI, and Related Technologies
The ABAIM plans to credential healthcare professionals and anyone else who seeks a greater
understanding of the growing role and use of artificial intelligence (AI), machine learning(ML), and deep learning (DL) solutions in health care.
LOS ANGELES (PRWEB) March 09, 2020 -- The American Board of Artificial Intelligence in Medicine(ABAIM) is pleased to announce its recent incorporation as a not-for-profit entity. The ABAIM plans tocredential healthcare professionals and anyone else who seeks a greater understanding of the growing role anduse of artificial intelligence (AI), machine learning (ML), and deep learning (DL) solutions in health care.
Spearheading this effort is Orest Boyko, MD, PhD, Associate Professor (Research) of Psychology at The USC
Michelson Center for Convergent Bioscience Bridge Institute, located at the University of Southern California;
and Anthony Chang, MD, Chief Intelligence and Innovation Officer at the Sharon Disney Lund Medical
Intelligence and Innovation Institute (MI3) at Children’s Hospital of Orange County, Orange, CA. Dr. Chang isalso the author of an upcoming book entitled Intelligence-Based Medicine: Principles and Applications ofArtificial Intelligence and Human Cognition in Clinical Medicine and Healthcare and is the Editor-in-Chief ofIntelligence-Based Medicine, an open access peer-review journal, published by Elsevier. Both are activelyinvolved in the development and application of AI, ML, and DL in medicine.
Co-chaired by Dr. Boyko and Dr. Chang, ABAIM’s growing board comprises professionals from an array ofmultidisciplinary and institutional backgrounds. These currently include: Matthew Lungren, MD, AssistantProfessor of Radiology, Stanford University Medical Center; Kevin Maher, Professor of Pediatrics, Emory
University School of Medicine; Spyro Mousses, PhD, CEO, Systems Oncology; Tanveer Syeda-Mahmood,PhD, IBM Fellow & Chief Scientist, IBM Research; Sharief Taraman, MD, Health Science Associate
Professor, UC Irvine School of Medicine; and Dennis Wall, PhD, Associate Professor of Pediatrics, Psychiatry,and Biomedical Data Science, Stanford Medical School.
Dr. Boyko, stated, “Artificial Intelligence and its related technologies are increasingly important not only toradiology and other medical imaging professionals, but also to health care as a whole, and I am grateful for thisopportunity the Department of Psychology and The USC Michelson Center for Convergent Bioscience Bridge
Institute have provided. This unique collaboration has enabled us to assemble the current stakeholders in a
unified effort to create a truly interdisciplinary educational approach to advance the adoption of AI, ML, andDL in health care.”
Dr. Chang continued, “The birth of the ABAIM is a tremendously exciting and major milestone in bringing AI
education and certification to all healthcare providers. The ABAIM’s modular curriculum will enable a widerange of healthcare professionals, including clinicians, executives, technicians, and nurses, as well as patients,
data scientists, and information technology personnel, to become knowledgeable in the application of AI, ML,and DL tools and technologies. Our vision of creating synergy between healthcare and AI-related technologies
will bring about a new paradigm of intelligence-based medicine and transform health care for everyone.”
Individuals who successfully complete a comprehensive, standardized exam developed by the ABAIM, which
has received an unrestricted educational grant from Guerbet, LLC, will receive Board certification. Thecertification will help ensure that these individuals have an advanced understanding of AI, ML, and DL, as well

PRWeb ebooks - Another online visibility tool from PRWebas the tools to analyze the benefits and pitfalls of these technologies in real-world scenarios. The ABAIM’s
ultimate goal is to enable healthcare professionals to participate in development, assessment, selection, andimplementation of AI, ML, and DL tools for their benefit and that of the institutions they serve today and in thefuture.
About ABAIM
The American Board of Artificial Intelligence in Medicine (ABAIM) was formed by Orest Boyko, MD, PhD
and Anthony Chang, MD, as a unique credentialing body for individuals who seek a greater knowledge andunderstanding of the roles of artificial intelligence, machine learning, and deep learning in health care andmedicine. Through board governance, the ABAIM is developing a series of credentialing exams designed tofoster greater knowledge and understanding of these technologies.
Media Relations
Orest Boyko, MD, PhD(215) 913-1002
boykoabaim@gmail.com
Anthony Chang, MD(714) 509-8220
Achang007@aol.com
About MI3The Sharon Disney Lund Medical Intelligence and Innovation Institute (MI3) at Children’s Hospital of Orange
County is a first-of-its-kind institute that creates, focuses and executes projects in the areas of artificial
intelligence and innovation in pediatric medicine. These two interrelated disciplines, extremely limited indevelopment in the pediatric realm, promise to change the trajectory of pediatric care around the world.
MI3 aims to foster robust development of artificial intelligence methodologies, as well as innovative advancesin emerging areas such as genomic medicine, regenerative medicine, robotics, nanotechnology, and medical
applications/devices. MI3 is dedicated to empowering data intelligence and medical innovation at CHOC and todriving innovation leadership in the international pediatrics community.
Media Relations
Julie Gillespie(714) 509-8220
Julie.Gillespie@choc.org

Page 2/3
If you have any questions regarding information in these press releases please contact the company listed in the press release. Our complete disclaimer
appears here - PRWeb ebooks - Another online visibility tool from PRWeb

Contact Information
Kieran N Anderson
Anderson Publishing, Ltd.
http://www.appliedradiology.com+1 (908) 301-1995 Ext: 1Online Web 2.0 Version
You can read the online version of this press release here.

Page 3/3
If you have any questions regarding information in these press releases please contact the company listed in the press release. Our complete disclaimer
appears here - PRWeb ebooks - Another online visibility tool from PRWeb